- Saudi Arabia
- /
- Healthcare Services
- /
- SASE:2230
Declining Stock and Decent Financials: Is The Market Wrong About Saudi Chemical Holding Company (TADAWUL:2230)?
It is hard to get excited after looking at Saudi Chemical Holding's (TADAWUL:2230) recent performance, when its stock has declined 9.0% over the past month. But if you pay close attention, you might find that its key financial indicators look quite decent, which could mean that the stock could potentially rise in the long-term given how markets usually reward more resilient long-term fundamentals. Particularly, we will be paying attention to Saudi Chemical Holding's ROE today.
Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. In simpler terms, it measures the profitability of a company in relation to shareholder's equity.
How Do You Calculate Return On Equity?
The formula for ROE is:
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity
So, based on the above formula, the ROE for Saudi Chemical Holding is:
13% = ر.س295m ÷ ر.س2.3b (Based on the trailing twelve months to September 2025).
The 'return' is the income the business earned over the last year. Another way to think of that is that for every SAR1 worth of equity, the company was able to earn SAR0.13 in profit.
Check out our latest analysis for Saudi Chemical Holding
What Has ROE Got To Do With Earnings Growth?
So far, we've learned that ROE is a measure of a company's profitability. Based on how much of its profits the company chooses to reinvest or "retain", we are then able to evaluate a company's future ability to generate profits. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features.
Saudi Chemical Holding's Earnings Growth And 13% ROE
It is hard to argue that Saudi Chemical Holding's ROE is much good in and of itself. An industry comparison shows that the company's ROE is not much different from the industry average of 15% either. Looking at Saudi Chemical Holding's exceptional 41% five-year net income growth in particular, we are definitely impressed. We reckon that there could also be other factors at play thats influencing the company's growth. For example, it is possible that the company's management has made some good strategic decisions, or that the company has a low payout ratio.
We then compared Saudi Chemical Holding's net income growth with the industry and we're pleased to see that the company's growth figure is higher when compared with the industry which has a growth rate of 17% in the same 5-year period.
Earnings growth is an important metric to consider when valuing a stock. It’s important for an investor to know whether the market has priced in the company's expected earnings growth (or decline). This then helps them determine if the stock is placed for a bright or bleak future. If you're wondering about Saudi Chemical Holding's's valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry.
Is Saudi Chemical Holding Using Its Retained Earnings Effectively?
Saudi Chemical Holding's three-year median payout ratio to shareholders is 17%, which is quite low. This implies that the company is retaining 83% of its profits. This suggests that the management is reinvesting most of the profits to grow the business as evidenced by the growth seen by the company.
Additionally, Saudi Chemical Holding has paid dividends over a period of at least ten years which means that the company is pretty serious about sharing its profits with shareholders.
Summary
Overall, we feel that Saudi Chemical Holding certainly does have some positive factors to consider. Despite its low rate of return, the fact that the company reinvests a very high portion of its profits into its business, no doubt contributed to its high earnings growth. While we won't completely dismiss the company, what we would do, is try to ascertain how risky the business is to make a more informed decision around the company. You can see the 1 risk we have identified for Saudi Chemical Holding by visiting our risks dashboard for free on our platform here.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SASE:2230
Saudi Chemical Holding
Manufactures, distributes, and retails medicines, medical materials and solutions, pharmaceutical preparations, medical and surgical tools, equipment, instruments, hospital and medical centre supplies and spare parts, detergents, and food products.
Excellent balance sheet with questionable track record.
Market Insights
Community Narratives


Recently Updated Narratives

Alphabet: The Under-appreciated Compounder Hiding in Plain Sight

MINISO's fair value is projected at 26.69 with an anticipated PE ratio shift of 20x

The Quiet Giant That Became AI’s Power Grid
Popular Narratives

The company that turned a verb into a global necessity and basically runs the modern internet, digital ads, smartphones, maps, and AI.

MicroVision will explode future revenue by 380.37% with a vision towards success
